# Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer

> clinical trial · VERIFIED · 2026-07-21

Status: COMPLETED · Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust · Condition: HER2 Negative Metastatic Breast Cancer

- Company: University Hospitals Bristol and Weston NHS Foundation Trust
- Sector: HER2 Negative Metastatic Breast Cancer
- Primary source: https://clinicaltrials.gov/study/NCT03048942

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.